Literature DB >> 26423432

Structural MRI substrates of cognitive impairment in neuromyelitis optica.

Yaou Liu1, Ying Fu1, Menno M Schoonheim2, Nan Zhang2, Moli Fan2, Lei Su2, Yi Shen2, Yaping Yan2, Li Yang2, Qiuhui Wang2, Ningnannan Zhang2, Chunshui Yu2, Frederik Barkhof2, Fu-Dong Shi2.   

Abstract

OBJECTIVE: To identify the clinical and structural MRI markers for predicting cognitive impairment (CI) in patients with neuromyelitis optica (NMO).
METHODS: Fifty-four patients with NMO and 27 healthy controls underwent extensive neuropsychological testing and multimodal 3.0T MRI. The patient group was classified as CI or cognitively preserved (CP), using a criterion of ≤1.5 SD on at least 2 cognitive domains. MRI measurements included white matter (WM) lesion volume, gray matter (GM), WM, and deep GM (DGM) volume, cortical thickness, and the severity and extent of WM tract diffusion metric alterations based on fractional anisotropy and mean, axial, and radial diffusivity. Groups were compared using a multivariate general linear model, and clinical and MRI measurements were related to average cognition z scores by partial correlations and a stepwise linear regression model.
RESULTS: Twenty-six patients with NMO (48.2%) were classified as CI and showed WM tract diffusion abnormalities, particularly increased radial diffusivity, and GM especially DGM atrophy compared with healthy controls. Patients classified as CP also showed alterations of WM tract diffusion but without significant GM atrophy. Compared with the CP group, patients with CI demonstrated a lower level of education and decreased hippocampal volume. In the whole patient group, average cognition z scores were best predicted by the level of education and hippocampal volume (R(2) = 0.46, p < 0.001).
CONCLUSION: In patients with NMO, WM tract integrity disruption was identified in both CP and CI groups. GM atrophy, particularly in the DGM, was only found in the CI group. Hippocampal volume is the main MRI predictor of cognition in NMO.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26423432     DOI: 10.1212/WNL.0000000000002067

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Screening for cognitive impairment among patients with neuromyelitis optica using touchscreen cognitive testing in routine clinical care.

Authors:  Jack Cotter; Fiona Trew; Shuna Colville; Dawn Lyle; Denise Cranley; Francesca Cormack; Jennifer H Barnett; Katy Murray; Suvankar Pal
Journal:  J Neurol       Date:  2019-06-20       Impact factor: 4.849

2.  Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.

Authors:  Carsten Finke; Hanna Zimmermann; Florence Pache; Frederike C Oertel; Velina Sevdalinova Chavarro; Yelyzaveta Kramarenko; Judith Bellmann-Strobl; Klemens Ruprecht; Alexander U Brandt; Friedemann Paul
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

3.  Altered neurovascular coupling in neuromyelitis optica.

Authors:  Xi Guo; Jiajia Zhu; Ningnannan Zhang; Linjie Zhang; Yuan Qi; Huanhuan Cai; Xue Zhang; Jie Sun; Qiuhui Wang; Li Yang; Fu-Dong Shi; Chunshui Yu
Journal:  Hum Brain Mapp       Date:  2018-10-13       Impact factor: 5.038

Review 4.  Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.

Authors:  Hao Meng; Jun Xu; Chenling Pan; Jiaxing Cheng; Yue Hu; Yin Hong; Yuehai Shen; Hua Dai
Journal:  J Neurol       Date:  2016-12-01       Impact factor: 4.849

5.  Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.

Authors:  Arman Eshaghi; Viktor Wottschel; Rosa Cortese; Massimiliano Calabrese; Mohammad Ali Sahraian; Alan J Thompson; Daniel C Alexander; Olga Ciccarelli
Journal:  Neurology       Date:  2016-11-02       Impact factor: 9.910

6.  Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Authors:  Omri Zveik; Ariel Rechtman; Nitzan Haham; Irit Adini; Tamar Canello; Iris Lavon; Livnat Brill; Adi Vaknin-Dembinsky
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

7.  Alterations in White Matter Fiber Tracts Characterized by Automated Fiber-Tract Quantification and Their Correlations With Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder Patients.

Authors:  Zichun Yan; Xiaohua Wang; Qiyuan Zhu; Zhuowei Shi; Xiaoya Chen; Yongliang Han; Qiao Zheng; Yiqiu Wei; Jingjie Wang; Yongmei Li
Journal:  Front Neurosci       Date:  2022-07-01       Impact factor: 5.152

Review 8.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

Review 9.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

10.  Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.

Authors:  Carsten Finke; Josephine Heine; Florence Pache; Anna Lacheta; Nadja Borisow; Joseph Kuchling; Judith Bellmann-Strobl; Klemens Ruprecht; Alexander U Brandt; Friedemann Paul
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.